SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001962918-24-000021
Filing Date
2024-03-20
Accepted
2024-03-20 07:04:42
Documents
14
Period of Report
2024-03-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K slrn-20240320.htm   iXBRL 8-K 29720
2 EX-99.1 slrn-8kx3202024xexx991.htm EX-99.1 29696
  Complete submission text file 0001962918-24-000021.txt   193972

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT slrn-20240320.xsd EX-101.SCH 1892
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT slrn-20240320_lab.xml EX-101.LAB 22530
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT slrn-20240320_pre.xml EX-101.PRE 13037
17 EXTRACTED XBRL INSTANCE DOCUMENT slrn-20240320_htm.xml XML 2815
Mailing Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301
Business Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301 805-871-4300
ACELYRIN, Inc. (Filer) CIK: 0001962918 (see all company filings)

IRS No.: 852406735 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41696 | Film No.: 24766251
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)